To explore the potential protective effect of STING agonists in breast cancer-induced bone destruction, we utilized the E0771 medullary breast carcinoma cell line to establish a syngeneic mouse model of breast cancer-induced bone cancer pain in female C57BL/6 mice, as 98% of all breast cancers occur in females38. This evidence concerns the gene STING1 and breast cancer.